MYK-461
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MYK-461, covering 2015-09-23 to 2020-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction [Phase 2]